Immunicum AB (publ) Stock Forecast

Immunicum AB (publ) stock downgraded from Buy Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Jun 20, 2024)

IMMU.ST Signals & Forecast

The Immunicum AB (publ) stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately kr9.16. On a fall, the stock will find some support from the long-term average at approximately kr3.81. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Immunicum AB (publ) has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 04, 2024, and so far it has fallen -10.39%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Immunicum AB (publ) stock

Immunicum AB (publ) finds support from accumulated volume at kr9.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved kr0.560 between high and low, or 6.41%. For the last week, the stock has had daily average volatility of 6.06%.

The Immunicum AB (publ) stock is extremely overbought on RSI14 (87). This increases the short-term risk substantially.

Our recommended stop-loss: kr8.75 (-4.30%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 87 and this increases the risk substantially. There is a sell signal from a pivot top found 25 days ago.)

Trading Expectations (IMMU.ST) For The Upcoming Trading Day Of Monday 24th

For the upcoming trading day on Monday, 24th we expect Immunicum AB (publ) to open at kr9.06, and during the day (based on 14 day Average True Range), to move between kr8.49 and kr9.79, which gives a possible trading interval of +/-kr0.653 (+/-7.15%) up or down from last closing price. If Immunicum AB (publ) takes out the full calculated possible swing range there will be an estimated 14.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at kr9.12 (0.22%) than the resistance at kr9.38 (2.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Immunicum AB (publ) stock A Buy?

Immunicum AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.889 Hold/Accumulate Downgraded

Predicted Opening Price for Immunicum AB (publ) of Monday, June 24, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.